Method of treatment

Details for Australian Patent Application No. 2002236141 (hide)

Owner Novartis International Pharmaceutical Ltd.

Inventors Serdarevic, Dzelal; Colli, Enrico; Skillern, Laurence Howard; Quinn, Paul

Agent Davies Collison Cave

Pub. Number AU-B-2002236141

PCT Pub. Number WO2003/051354

Priority 0129962.7 14.12.01 GB

Filing date 5 March 2002

Wipo publication date 30 June 2003

Acceptance publication date 1 February 2007

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

Event Publications

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002236141

1 February 2007 Application Accepted

  Published as AU-B-2002236141

31 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236142-Metal-based anodes for aluminium production cells

2002236140-METHOD AND DEVICE FOR ACCESSING FILES STORED IN A MOBILE TERMINAL DEVICE SUPPORTING AN INTERNET PROTOCOL